Laverock Therapeutics raised €23.3m in seed funding led by Calculus Capital, joined by Eli Lilly, Mercia Ventures, Eos Advisory, Maven Capital and Norcliffe.
01 June 2025
01 June 2025
Total investments received (USD): 43.99M
Round value (USD): 26.84M
Company: Laverock Therapeutics
Related deals
Fyxer raised a $30m Series B led by Madrona, with participation from Lakestar.
Investments
01 September 2025
Cyted Health raises €37.5 million in a Series B financing round led by EQT Life Sciences, Advent Life and British Business Bank, w/ Morningside and BGF.
Investments
01 August 2025
Monet to raise £17m in a seed round with Force Over Mass and British angel investors.
Investments
24 June 2025
Portal Biotech raised $35m Series A round co-led by NATO and Earlybird, joined by SCVC, Pillar VC, 8VC, Amino Collective, Outsized, We Venture Capital.
Investments
20 June 2025
Metaview raised $35m in Series B funding led by GV, joined by Plural, Vertex Ventures, Seedcamp, Coelius Capital, and True Equity.
Investments
13 June 2025
Netherlands
Austria
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal